For patients with PSP, although several 18F-T807 studies have suggested limited findings (Coakeley et al., 2017; Marqui et al., 2017), recent studies have revealed group differences between PSP and PD or healthy controls by 18F-T807 tau PET images. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.